The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. GeneDx Holdings Corp shares valued at $27,128 were sold by Feeley Kevin on Mar 03 ’25. At $103.94 per share, Feeley Kevin sold 261 shares. The insider’s holdings dropped to 3,906 shares worth approximately $0.41 million following the completion of this transaction.
Also, Kevin Feeley purchased 261 shares, netting a total of over 27,100 in proceeds.
Before that, ICAHN SCHOOL OF MEDICINE AT MO had added 373,569 shares to its account. In a trade valued at $35,799,117, the Stockholder bought GeneDx Holdings Corp shares for $95.83 each.
As published in their initiating research note from Wells Fargo on August 28, 2024, GeneDx Holdings Corp [WGS] has been an Equal weight and the price target has been revised to $34. Analysts at Craig Hallum started covering the stock with ‘”a Buy”‘ outlook in a report released in early July.
Analyzing WGS Stock Performance
During the last five days, there has been a surge of approximately 6.23%. Over the course of the year, GeneDx Holdings Corp shares have jumped approximately 37.02%. Shares of the company reached a 52-week high of $115.60 on 02/19/25 and a 52-week low of $58.62 on 02/07/25. A 50-day SMA is recorded $82.23, while a 200-day SMA reached $54.31.
Support And Resistance Levels for GeneDx Holdings Corp (WGS)
According to the 24-hour chart, there is a support level at 99.07, which, if violated, would cause prices to drop to 92.83. In the upper region, resistance lies at 108.61. The next price resistance is at 111.91. RSI (Relative Strength Index) is 62.15 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.82, which suggests the price will increase in the coming days. Percent R is at 22.88%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
